Nov. 26, 2003: Lupron Depot- 3 month 22.5 mg (leuprolide acetate for depot suspension).
The FDA reports that the medication has been associated with low blood pressure (hypotension), pulmonary embolisms, and changes in bone density. The agency advises those seeking more information to contact the manufacturer TAP Pharmaceuticals at 1-800-622-2011. www.fda.gov/medwatch/SAFETY/2003/sep03.htm - 11-26-2003 - Cached Nov. 26, 2003 Lupron Depot – 4 month 30 mg (leuprolide acetate for depot suspension)
The FDA notes changes in the adverse reactions section regarding the cardiovascular system and pulmonary embolism. For more information, contact the manufacturer TAP Pharmaceuticals at 1-800-622-2011. www.fda.gov/medwatch/SAFETY/2003/sep03.htm - 11-26-2003 - Cached November 7, 2003 Cytotec (misoprostol) tablets
The new drug safety alert posted by the FDA advises that doctors should be cautious about giving Cytotec to patients with pre-existing cardiovascular conditions. Chest pain, fluid retention and irregular heartbeat are some of the reported adverse reactions to taking Cytotec. To print out this safety alert to discuss with your doctor, click here.www.fda.gov/medwatch/SAFETY/2003/03AUG_PI/Cytotec_PI.pdf Other sources
 National Infertility Association |
| American Infertility Association |
(List of fertility drugs )
First published July 21, 2003
Copyright © 2003 Consumer Health Interactive
| 
